Omega Healthcare Investors (NYSE:OHI) Issues FY 2024 Earnings Guidance

Omega Healthcare Investors (NYSE:OHI) issued an update on its FY 2024 earnings guidance on Friday morning. The company provided earnings per share (EPS) guidance of 2.700-2.800 for the period, compared to the consensus estimate of 2.730. The company issued revenue guidance of -.

Omega Healthcare Investors Price Performance

NYSE OHI traded down $0.22 on Monday, reaching $31.12. The company’s stock had a trading volume of 803,785 shares, compared to its average volume of 1,739,825. Omega Healthcare Investors has a 52 week low of $27.53 and a 52 week high of $34.77. The company has a current ratio of 6.68, a quick ratio of 6.76 and a debt-to-equity ratio of 1.36. The firm has a market cap of $7.68 billion, a PE ratio of 28.07, a price-to-earnings-growth ratio of 10.26 and a beta of 0.92. The business has a 50-day moving average price of $30.98 and a 200 day moving average price of $30.97.

Omega Healthcare Investors Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Tuesday, April 30th will be issued a $0.67 dividend. The ex-dividend date of this dividend is Monday, April 29th. This represents a $2.68 dividend on an annualized basis and a dividend yield of 8.61%. Omega Healthcare Investors’s payout ratio is presently 241.44%.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on OHI shares. Bank of America cut shares of Omega Healthcare Investors from a buy rating to a neutral rating and cut their target price for the company from $33.00 to $31.00 in a research note on Tuesday, January 16th. Deutsche Bank Aktiengesellschaft assumed coverage on Omega Healthcare Investors in a research note on Tuesday, January 30th. They issued a buy rating and a $36.00 target price on the stock. JMP Securities reaffirmed a market perform rating on shares of Omega Healthcare Investors in a research note on Monday. Citigroup raised shares of Omega Healthcare Investors from a neutral rating to a buy rating and lifted their price objective for the stock from $32.00 to $35.00 in a research note on Friday, March 22nd. Finally, Truist Financial increased their target price on shares of Omega Healthcare Investors from $31.00 to $32.00 and gave the stock a hold rating in a report on Tuesday, April 2nd. Eight research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, Omega Healthcare Investors presently has a consensus rating of Hold and an average target price of $33.63.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.